Application of 5908-62-3, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, Application of 5908-62-3, name is 1,1-Dioxo-isothiazolidine, introducing its new discovery.
EP4 ANTAGONIST
To provide a drug including a compound having an antagonistic activity with respect to EP4 receptor in preventing and/or treating the disease caused by activation of an EP4 receptor as an active ingredient. A compound represented by the general formula (I): (wherein in the formula, all the symbols have the same meanings as those described in the description), or a pharmaceutically acceptable salt thereof is useful as a medicament component having an EP4 receptor antagonistic activity, in preventing and/or treating the disease caused by activation of an EP4 receptor.
The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 5908-62-3 is helpful to your research. Application of 5908-62-3
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H500N | ChemSpider